WallStSmart

POMDOCTOR LIMITED American Depositary Shares (POM)vsRidgetech, Inc. (RDGT)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

POMDOCTOR LIMITED American Depositary Shares generates 211% more annual revenue ($410.44M vs $132.16M). RDGT leads profitability with a -0.9% profit margin vs -90.2%. RDGT earns a higher WallStSmart Score of 39/100 (F).

POM

Avoid

26

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -33.39

RDGT

Hold

39

out of 100

Grade: F

Growth: 4.7Profit: 4.0Value: 6.7Quality: 8.0
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for POM.

RDGTUndervalued (+82.5%)

Margin of Safety

+82.5%

Fair Value

$10.18

Current Price

$0.83

$9.35 discount

UndervaluedFair: $10.18Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

POM1 strengths · Avg: 10.0/10
Debt/EquityHealth
-0.9610/10

Conservative balance sheet, low leverage

RDGT4 strengths · Avg: 9.5/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
30.2%10/10

Every $100 of equity generates 30 in profit

Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

POM4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$10.84M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

RDGT4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$3.03M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-6.74M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-0.9%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : POM

The strongest argument for POM centers on Debt/Equity.

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Free Cash Flow.

Key Dynamics to Monitor

POM profiles as a turnaround stock while RDGT is a growth play — different risk/reward profiles.

RDGT is growing revenue faster at 21.4% — sustainability is the question.

POM generates stronger free cash flow (1M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RDGT scores higher overall (39/100 vs 26/100) and 21.4% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?